Company page
Medigen Vaccine Biologics Corp.
Medigen Vaccine Biologics Corp. is a publicly traded company on the Taiwan stock market under the ticker 6547. The company has a market capitalization of approximately NT$468.8 million. Medigen focuses on the development and production of vaccines, contributing to public health initiatives.
- Ticker
- 6547:TPEX
- Asset type
- Stock
- Market cap
- $468.8M
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- TPEX
- Currency
- TWD